Science Explorer Back to mapMap
Discussion
Researcher · Toneyama National Hospital · Japan

Yoshinobu Namba

Yoshinobu Namba publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Diagnosis and Treatment.

OpenAlex
World rank
#1,507,070
of 7,710,434 ranked researchers
Rank in Japan
#24,081
of 383,136
Works
53
Citations
1.6k
Citations per work
30.5
h-index
15
i10-index 21Top 31% in Pulmonary and Respiratory Medicine
Yoshinobu Namba

What does Yoshinobu Namba research?

Yoshinobu Namba's work is mostly in Medicine (84%).

Health Sciences: 45 works · 84.0% of their workMedicine: 45 works · 84.0% of their workPulmonary and Respiratory Medicine: 21 works · 39.2% of their workOncology: 16 works · 29.6% of their workSurgery: 4 works · 8.0% of their workEpidemiology: 2 works · 3.2% of their workHematology: 1 works · 2.4% of their workRheumatology: 1 works · 1.6% of their workEverything else: 8 works · 16.0% of their workTHEIR WORKYoshinobu Namba53works
Health Sciences84%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4584.0%
  2. Everything else816.0%
  1. 1Pulmonary and Respiratory Medicine39% of their works
  2. 2Oncology30% of their works
  3. 3Surgery8% of their works
  4. 4Epidemiology3% of their works
  5. 5Hematology2% of their works
  6. 6Rheumatology2% of their works

Research topics

Which keywords describe Yoshinobu Namba's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Immune Checkpoint Blockade, PD-1 and PD-L1 and CT Screening.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy223 topics
  2. Clinical Trials212 topics
  3. Targeted Therapy212 topics
  4. ALK Inhibitors181 topic
  5. EGFR Mutations181 topic
  6. Immune Checkpoint Blockade141 topic
  7. PD-1 and PD-L1141 topic
  8. CT Screening111 topic
  9. Lung Cancer111 topic
  10. Cetuximab81 topic
  11. KRAS Mutations81 topic
  12. Prognostic Factors82 topics
  13. Biliary Tract Cancer51 topic
  14. Cholangiocarcinoma51 topic
  15. Empyema41 topic
  16. Pleural Effusion41 topic
  17. Pulmonary Alveolar Microlithiasis41 topic
  18. Pulmonary Sclerosing Hemangioma41 topic
  19. Genomic Profiles31 topic
  20. Small-Cell Lung Cancer31 topic

Where does Yoshinobu Namba work?

Yoshinobu Namba's main affiliation in the publication record is Toneyama National Hospital, Japan.

How many publications and citations does Yoshinobu Namba have?

OpenAlex counts 53 works and 1,618 citations for Yoshinobu Namba, an h-index of 15, ranking #1,507,070 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yoshinobu Namba. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.